203 related articles for article (PubMed ID: 34777351)
1. Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews.
Juvet LK; Robertson AH; Laake I; Mjaaland S; Trogstad L
Front Immunol; 2021; 12():740048. PubMed ID: 34777351
[TBL] [Abstract][Full Text] [Related]
2. No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland.
Melén K; Partinen M; Tynell J; Sillanpää M; Himanen SL; Saarenpää-Heikkilä O; Hublin C; Olsen P; Ilonen J; Nohynek H; Syrjänen R; Kilpi T; Vuorela A; Kirjavainen T; Vaarala O; Julkunen I
PLoS One; 2013; 8(8):e68402. PubMed ID: 23950869
[TBL] [Abstract][Full Text] [Related]
3. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden.
Bardage C; Persson I; Ortqvist A; Bergman U; Ludvigsson JF; Granath F
BMJ; 2011 Oct; 343():d5956. PubMed ID: 21994316
[TBL] [Abstract][Full Text] [Related]
4. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N;
Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus.
Saariaho AH; Vuorela A; Freitag TL; Pizza F; Plazzi G; Partinen M; Vaarala O; Meri S
J Autoimmun; 2015 Sep; 63():68-75. PubMed ID: 26227560
[TBL] [Abstract][Full Text] [Related]
6. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe.
Romio S; Weibel D; Dieleman JP; Olberg HK; de Vries CS; Sammon C; Andrews N; Svanström H; Mølgaard-Nielsen D; Hviid A; Lapeyre-Mestre M; Sommet A; Saussier C; Castot A; Heijbel H; Arnheim-Dahlström L; Sparen P; Mosseveld M; Schuemie M; van der Maas N; Jacobs BC; Leino T; Kilpi T; Storsaeter J; Johansen K; Kramarz P; Bonhoeffer J; Sturkenboom MC
PLoS One; 2014; 9(1):e82222. PubMed ID: 24404128
[TBL] [Abstract][Full Text] [Related]
7. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.
Dodd CN; Romio SA; Black S; Vellozzi C; Andrews N; Sturkenboom M; Zuber P; Hua W; Bonhoeffer J; Buttery J; Crawford N; Deceuninck G; de Vries C; De Wals P; Gutierrez-Gimeno MV; Heijbel H; Hughes H; Hur K; Hviid A; Kelman J; Kilpi T; Chuang SK; Macartney K; Rett M; Lopez-Callada VR; Salmon D; Gimenez-Sanchez F; Sanz N; Silverman B; Storsaeter J; Thirugnanam U; van der Maas N; Yih K; Zhang T; Izurieta H;
Vaccine; 2013 Sep; 31(40):4448-58. PubMed ID: 23770307
[TBL] [Abstract][Full Text] [Related]
8. Meeting report narcolepsy and pandemic influenza vaccination: What we know and what we need to know before the next pandemic? A report from the 2nd IABS meeting.
Edwards K; Hanquet G; Black S; Mignot E; Jankosky C; Shimabukuro T; Miller E; Nohynek H; Neels P
Biologicals; 2019 Jul; 60():1-7. PubMed ID: 31130313
[TBL] [Abstract][Full Text] [Related]
9. Safety of AS03-adjuvanted influenza vaccines: A review of the evidence.
Cohet C; van der Most R; Bauchau V; Bekkat-Berkani R; Doherty TM; Schuind A; Tavares Da Silva F; Rappuoli R; Garçon N; Innis BL
Vaccine; 2019 May; 37(23):3006-3021. PubMed ID: 31031030
[TBL] [Abstract][Full Text] [Related]
10. Change in risk for narcolepsy over time and impact of definition of onset date following vaccination with AS03 adjuvanted pandemic A/H1N1 influenza vaccine (Pandemrix) during the 2009 H1N1 influenza pandemic.
Granath F; Gedeborg R; Smedje H; Feltelius N
Pharmacoepidemiol Drug Saf; 2019 Aug; 28(8):1045-1053. PubMed ID: 31062443
[TBL] [Abstract][Full Text] [Related]
11. A/H1N1 pandemic influenza vaccination: A retrospective evaluation of adverse maternal, fetal and neonatal outcomes in a cohort of pregnant women in Italy.
Fabiani M; Bella A; Rota MC; Clagnan E; Gallo T; D'Amato M; Pezzotti P; Ferrara L; Demicheli V; Martinelli D; Prato R; Rizzo C
Vaccine; 2015 May; 33(19):2240-2247. PubMed ID: 25820060
[TBL] [Abstract][Full Text] [Related]
12. Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants.
Ahmed SS; Schur PH; MacDonald NE; Steinman L
J Autoimmun; 2014 May; 50():1-11. PubMed ID: 24559657
[TBL] [Abstract][Full Text] [Related]
13. Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines - Multi-country assessment.
Weibel D; Sturkenboom M; Black S; de Ridder M; Dodd C; Bonhoeffer J; Vanrolleghem A; van der Maas N; Lammers GJ; Overeem S; Gentile A; Giglio N; Castellano V; Kwong JC; Murray BJ; Cauch-Dudek K; Juhasz D; Campitelli M; Datta AN; Kallweit U; Huang WT; Huang YS; Hsu CY; Chen HC; Giner-Soriano M; Morros R; Gaig C; Tió E; Perez-Vilar S; Diez-Domingo J; Puertas FJ; Svenson LW; Mahmud SM; Carleton B; Naus M; Arnheim-Dahlström L; Pedersen L; DeStefano F; Shimabukuro TT
Vaccine; 2018 Oct; 36(41):6202-6211. PubMed ID: 30122647
[TBL] [Abstract][Full Text] [Related]
14. Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series.
Andrews N; Stowe J; Al-Shahi Salman R; Miller E
Vaccine; 2011 Oct; 29(45):7878-82. PubMed ID: 21875631
[TBL] [Abstract][Full Text] [Related]
15. Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk.
Vaarala O; Vuorela A; Partinen M; Baumann M; Freitag TL; Meri S; Saavalainen P; Jauhiainen M; Soliymani R; Kirjavainen T; Olsen P; Saarenpää-Heikkilä O; Rouvinen J; Roivainen M; Nohynek H; Jokinen J; Julkunen I; Kilpi T
PLoS One; 2014; 9(12):e114361. PubMed ID: 25501681
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis.
Yin JK; Khandaker G; Rashid H; Heron L; Ridda I; Booy R
Influenza Other Respir Viruses; 2011 Sep; 5(5):299-305. PubMed ID: 21668694
[TBL] [Abstract][Full Text] [Related]
17. Risk of Narcolepsy after AS03 Adjuvanted Pandemic A/H1N1 2009 Influenza Vaccine in Adults: A Case-Coverage Study in England.
Stowe J; Andrews N; Kosky C; Dennis G; Eriksson S; Hall A; Leschziner G; Reading P; Shneerson JM; Donegan K; Miller E
Sleep; 2016 May; 39(5):1051-7. PubMed ID: 26856903
[TBL] [Abstract][Full Text] [Related]
18. The Effects of Influenza Vaccination during Pregnancy on Birth Outcomes: A Systematic Review and Meta-Analysis.
Nunes MC; Aqil AR; Omer SB; Madhi SA
Am J Perinatol; 2016 Sep; 33(11):1104-14. PubMed ID: 27603545
[TBL] [Abstract][Full Text] [Related]
19. A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.
Lind A; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Nilsson AL; Bomfim IL; Fink K; Lernmark Å
J Autoimmun; 2014 May; 50():99-106. PubMed ID: 24485154
[TBL] [Abstract][Full Text] [Related]
20. [Safety and effectiveness of the influenza vaccine: new data, new challenges].
Trilla A
Med Clin (Barc); 2013 Jul; 141(2):67-9. PubMed ID: 23768850
[No Abstract] [Full Text] [Related]
[Next] [New Search]
